These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28484805)

  • 1. [Practical guidelines for genetic testing in cardiovascular diseases].
    Reinhard W; Trenkwalder T; Schunkert H
    Herz; 2017 Aug; 42(5):485-491. PubMed ID: 28484805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. German Ethics Council on genetic diagnostics: trend setting?
    Buechner B
    Eur J Hum Genet; 2014 Jun; 22(6):831-2. PubMed ID: 24169520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human Genetics.
    Mogensen J; van Tintelen JP; Fokstuen S; Elliott P; van Langen IM; Meder B; Richard P; Syrris P; Caforio AL; Adler Y; Anastasakis A; Gimeno JR; Klingel K; Linhart A; Imazio M; Pinto Y; Newbery R; Schmidtke J; Charron P
    Eur Heart J; 2015 Jun; 36(22):1367-70. PubMed ID: 25845928
    [No Abstract]   [Full Text] [Related]  

  • 4. NGS-Based genetic testing for heritable cardiovascular diseases. Specific requirements for obtaining informed consent.
    Schmidtke J; Wittkowski K; Glaubitz R
    Mol Cell Probes; 2019 Jun; 45():70-78. PubMed ID: 31059777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Testing in Cardiovascular Medicine.
    Marian AJ
    Tex Heart Inst J; 2018 Aug; 45(4):231-232. PubMed ID: 30374232
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics and cardiovascular disease: the impact of molecular diagnosis.
    Vengoechea J; McKelvey KD
    J Ark Med Soc; 2013 Apr; 109(11):230-2. PubMed ID: 23691714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing: medico-legal issues.
    Bird S
    Aust Fam Physician; 2014 Jul; 43(7):481-2. PubMed ID: 25006613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing for inherited cardiovascular diseases. A position statement of the Polish Cardiac Society endorsed by Polish Society of Human Genetics and Cardiovascular Patient Communities.
    Biernacka EK; Osadnik T; Bilińska ZT; Krawczyński M; Latos-Bieleńska A; Łaczmańska I; Miszczak-Knecht M; Płoski R; Ponińska JK; Prejbisz A; Rubiś P; Rudnicka A; Szczałuba K; Szczygieł JA; Własienko P; Wołczenko A; Zienciuk-Krajka A; Ziółkowska L; Gil R
    Kardiol Pol; 2024; 82(5):569-593. PubMed ID: 38712785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERRATUM: Genetic testing for inherited cardiovascular diseases. A position statement of the Polish Cardiac Society endorsed by Polish Society of Human Genetics and Cardiovascular Patient Communities.
    Biernacka EK; Osadnik T; Bilińska ZT; Krawczyński M; Latos-Bieleńska A; Łaczmańska I; Miszczak-Knecht M; Płoski R; Ponińska JK; Prejbisz A; Rubiś P; Rudnicka A; Szczałuba K; Szczygieł JA; Własienko P; Wołczenko A; Zienciuk-Krajka A; Ziółkowska L; Gil R
    Kardiol Pol; 2024; 82(6):687. PubMed ID: 38973419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
    Vrablik M; Dlouha D; Todorovova V; Stefler D; Hubacek JA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal and ethical implications of inherited cardiac disease in clinical practice within the UK.
    Hall AE; Burton H
    J Med Ethics; 2010 Dec; 36(12):762-6. PubMed ID: 21112937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing in cardiovascular medicine: current landscape and future horizons.
    Sturm AC; Hershberger RE
    Curr Opin Cardiol; 2013 May; 28(3):317-25. PubMed ID: 23571470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Something Old, Something New: Using Family History and Genetic Testing to Diagnose and Manage Athletes with Inherited Cardiovascular Disease.
    Thomas MJ; Battle RW
    Clin Sports Med; 2015 Jul; 34(3):517-37. PubMed ID: 26100426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Testing for Inherited Cardiovascular Disease: Implications of the AHA Scientific Statement for Cardiologists.
    Gray B; Semsarian C
    Heart Lung Circ; 2020 Nov; 29(11):1581-1584. PubMed ID: 33008731
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical, legal, and social dimensions of epilepsy genetics.
    Shostak S; Ottman R
    Epilepsia; 2006 Oct; 47(10):1595-602. PubMed ID: 17054679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic testing, screening, and counseling issues in cardiovascular disease.
    Lashley FR
    J Cardiovasc Nurs; 1999 Jul; 13(4):110-26. PubMed ID: 10386275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expansion of Genetic Testing in Cardiovascular Medicine: Preparing the Cardiology Community for the Changing Landscape.
    Reza N; Alford RL; Belmont JW; Marston N
    Curr Cardiol Rep; 2024 Mar; 26(3):135-146. PubMed ID: 38277082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing and genetic counseling in cardiovascular genetic medicine: overview and preliminary recommendations.
    Cowan J; Morales A; Dagua J; Hershberger RE
    Congest Heart Fail; 2008; 14(2):97-105. PubMed ID: 18401220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of direct-to-consumer genetic testing for cardiovascular disease risk.
    Austin SE; Hegele RA
    Can J Cardiol; 2011; 27(6):682-4. PubMed ID: 21652171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.